BNET Industries

Calypte Biomedical Corp.

(CBMC) is in the Health Care Industry

Market Cap:$4.6M
Last Fiscal Year Sales:$589.0K
  • Public
  • US
Dow Jones Description

Calypte Biomedical Corporation is a U.S.-based healthcare company focused on the development and commercialization of rapid testing products for sexually transmitted diseases such as the Aware(R) HIV-1/2 OMT test that are suitable for use at the point of care and at home. Calypte believes there is a significant need for rapid detection of such diseases globally to control their proliferation, particularly in developing countries, which lack the medical infrastructure to support laboratory-based testing. Calypte believes that testing for HIV and other sexually transmitted infectious diseases may make important contributions to public health, and could increase the likelihood of treating those with undetected HIV and other sexually transmitted diseases.

CFO & Vice President
Richard D. Brounstein
Number of Employees 1
Contact Information

5 Centerpointe Drive

Suite 400

Lake Oswego, Oregon 97035

www.calypte.com

(971) 204-0282

NAICS Code Analytical Laboratory Instrument Manufacturing: 334516

Recent Events

  • Calypte Biomedical Announces Changes to its Board of Directors

    9/25/09 - Board Member - Leaving - View Story

News & Analysis

calypte biomedical corp. and investment - All News and Analysis

Decision Makers

Name (plus bio) Position
Richard D. Brounstein CFO & Vice President
Ronald W. Mink Chief Science Officer
Theodore R. Gwin CFO
Richard Van Maanen Vice President, Operations
Luc Montagnier Director, Oncology

Board of Directors

Name (plus bio) Position
Anthony J. Cataldo Executive Chairman
John J. Dipietro Board of Directors
Julius R. Krevans Board of Directors
Paul E. Freiman Board of Directors
Zafar I. Randawa Board of Directors

Organization Position Status
Calypte Biomedical Corporation CFO & Vice President Current

Organization Position Status
Calypte Biomedical Corporation Chief Science Officer Current

Organization Position Status
Calypte Biomedical Corporation CFO Current

Organization Position Status
Calypte Biomedical Corporation Vice President, Operations Current

Organization Position Status
Calypte Biomedical Corporation Director, Oncology Current
Calypte Biomedical Corporation Director, Oncology Former

Anthony J. Cataldo, age 55 became our Chief Executive Officer and Chairman in September 2006. During the past five (5) years, Mr. Cataldo has served as non-executive chairman of the board of directors of BrandPartners Group, Inc. (OTC BB:BPTR) a provider of integrated products and services dedicated to providing financial services and traditional retail clients with turn-key environmental solutions from October 2003 through August 2006. Mr. Cataldo also served as non-executive co-chairman of the board of MultiCell Technologies, Inc. (OTC BB: MUCL) a supplier of functional, non-tumorigenic immortalized human hepatocytes from February 2005 through July 2006. Mr. Cataldo has also served as executive chairman of Calypte Biomedical Corporation (AMEX: HIV), a publicly traded biotechnology company, involved in development and sale of urine based HIV-1 screening test from May 2002 through November 2004. Prior to that, Mr. Cataldo served as the Chief Executive Officer and Chairman of the Board of Directors of Miracle Entertainment, Inc., a Canadian film production company, from May 1999 through May 2002 where he was the executive producer or producer of several motion pictures. From August 1995 to December 1998, Mr. Cataldo served as President and Chairman of the Board of Senetek, PLC (OTC BB:SNTKY), a publicly traded biotechnology company involved in age-related therapies.

Organization Position Status
Calypte Biomedical Corporation Executive Chairman Current
Calypte Biomedical Corporation Board of Directors Current
VoIP, Inc. CEO and Chairman Former
Miracle Entertainment, Inc Chief Executive Officer Former
Internet Systems President Former
Miracle Entertainment, Inc Producer Former
Senetek PLC Chairman of the Board Former
BrandPartners Group Chairman Former
Miracle Entertainment, Inc Chairman of the Board of Directors Former
Multicell Technologies, Inc. Chairman of the Board Former
BrandPartners Group Board of Directors Former

Organization Position Status
Calypte Biomedical Corporation Board of Directors Current
Tripath Technology, Inc. Chief Financial Officer Former
Tripath Technology, Inc. Vice President, Finance & Administration Former
University of Chicago M.B.A. Former

Company since May 1994 and as Chairman of the Board of Directors of our Company since February 1999. Dr. Krevans served as Chancellor of the University of California, San Francisco from July 1982 until May 1993. Prior to his appointment as Chancellor, Dr. Krevans served as a Professor of Medicine and Dean of the School of Medicine at the University of California, San Francisco from 1971 to 1982. Dr. Krevans is a member of the Institute of Medicine, National Academy of Sciences, and led its committee for the National Research Agenda on Aging until 1991. Dr. Krevans also serves on the Board of Directors and the compensation committee of the Board of Directors of Calypte Biomedical corporation (Calypte), a publicly held corporation. Dr.Krevans has a B.S. degree and a M.D. degree, both from New York University.

Organization Position Status
National Academy of Sciences Member Current
Neoprobe Corporation Chairman Current
Neoprobe Corporation Board of Directors Current
Calypte Biomedical Corporation Board of Directors Current
University of California, San Francisco Director of International Medical Care Former
University of California, San Francisco Professor of Medicine Former
New York University M.D. Degree Former
New York University B.S. Degree Former
Johns Hopkins University School of Medicine residency in Medicine Former

Organization Position Status
Syntex Corporation Chief Executive Officer Current
Neurobiological Technologies, Inc. President & CEO Current
Scigen Ltd Leading Independant Director Current
Penwest Pharmaceuticals, Co. Chairman Current
Omware, Inc. Director Current
Phytos Inc Director Current
NovaBay Pharmaceuticals, Inc. Board of Directors Current
Scigen Ltd Board of Directors Current
NeoPharm, Inc. Board of Directors Current
Novacal Pharmaceuticals, Inc. Board of Directors Current
Calypte Biomedical Corporation Board of Directors Current
Neurobiological Technologies, Inc. Board of Directors Current
Syntex Corporation chairman Former
Penwest Pharmaceuticals, Co. Board of Directors Former
Calypte Biomedical Corporation Director Former
Nti, Inc. Director Former
Fordham University B.S. Degree In Pharmacy Former

Organization Position Status
Calypte Biomedical Corporation Board of Directors Current
advertisement
     CBMC $0.01 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 177,163
Shares Outstanding 439.35M
Market Cap 4.4M
Year High 0.018
Year Low 0.004
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express